In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Selfcare raises $9.3mm in IPO of 1.3mm shares at $8.50 a share
13 Jul 1999
Selfcare (self-test diagnostics in women's health, diabetes and infectious diseases) raised net proceeds of $9.3mm in its IPO of 1.3mm shares of common stock at $8.50 per share. The company originally offered 2.8mm shares, hoping to net $30mm.
In Vitro Diagnostics
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?